2月27日，欧康医药盘中上涨5.88%，截至14:27，报17.48元/股，成交2828.04万元，换手率4.95%，总市值13.51亿元。
资料显示，成都欧康医药股份有限公司位于四川省邛崃市临邛工业园区创业路15号，公司是一家专业从事天然维生素P类植物的种植、提取、纯化、合成及运用的高新技术企业，主要为欧、美、日市场提供天然维生素P类原料药、保健品、功能食品、化妆品原料的生产供应。公司已有20余年的专业研究和生产经验，致力于打造全球最专业的天然维生素P运用中心。
截至9月30日，欧康医药股东户数7038，人均流通股4757股。
2024年1月-9月，欧康医药实现营业收入2.24亿元，同比增长31.83%；归属净利润1952.61万元，同比增长54.23%。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.